FOLH1 and prostate cancer: In the laboratory, fluorescent CNT composites were exposed in vitro to PSMA+ HCT-116 LNCaP prostate cancer cells, PSMA CaCo-2 colon cancer cells, and PSMA human peripheral monocytes and lymphocytes.